Table 2. Antiparkinsonian and other medication use.

	Median (range) or number (%)		Significance P-value
	Fallers (n=27)	Non-fallers (n=60)
Dopaminergic medication
LEU (mg)	734.3 (1616.7)	330.8 (1700)	0.009
Levodopa	22/27 (81%)	36/60 (60%)	0.05
Dopamine agonist	17/27 (46%)	32/60 (53%)	0.40
MAOB inhibitor	3/27 (11%)	8/60 (13%)	0.77
COMT inhibitor	10/27 (37%)	14/60 (23%)	0.19
Amantadine	7/27 (26%)	4/60 (7%)	0.01
Other medication
Antidepressants	10/27 (37%)	4/60 (7%)	<0.001
Neuroleptics	11/27 (41%)	5/60 (8%)	<0.001
Sleep medication	2/27 (7%)	3/60 (5%)	0.66

Abbreviation: LEU, Levodopa-equivalent unit.